ORAGENICS INC
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
OGEN$0.34-3.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Operating expenses: | ||||
| Research and development | $930,894 | $879,041 | $1,722,115 | $2,449,234 |
| General and administrative | 2,192,879 | 1,558,239 | 5,142,087 | 4,754,149 |
| Total operating expenses | 3,123,773 | 2,437,280 | 6,864,202 | 7,203,383 |
| Loss from operations | (3,123,773) | (2,437,280) | (6,864,202) | (7,203,383) |
| Other income (expense): | ||||
| Interest income | 68,142 | 9,466 | 95,138 | 35,106 |
| Interest expense | (7,039) | (9,971) | (778,476) | (18,859) |
| Foreign currency exchange net | (3,919) | (25,085) | (8,077) | (31,659) |
| Total other income (expense), net | 57,184 | (25,590) | (691,415) | (15,412) |
| Net loss | $(3,066,589) | $(2,462,870) | $(7,555,617) | $(7,218,795) |
| Basic and diluted net loss per share | $(1.96) | $(11.32) | $(5.16) | $(101.37) |
| Weight average shares outstanding, basic and diluted | 1,560,909 | 217,602 | 1,464,689 | 71,211 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.